EP Patent

EP2127628A1 — Unit dose pack

Assigned to Ranbaxy Laboratories Ltd · Expires 2009-12-02 · 16y expired

What this patent protects

It relates to a unit dose pack for pharmaceutical composition of atorvastatin comprising a base part and a cover part wherein the base part is made up of multilayer laminate comprising an inner layer of polyvinyl chloride, a layer of coextruded polyethylene and an outer layer of …

USPTO Abstract

It relates to a unit dose pack for pharmaceutical composition of atorvastatin comprising a base part and a cover part wherein the base part is made up of multilayer laminate comprising an inner layer of polyvinyl chloride, a layer of coextruded polyethylene and an outer layer of polyvinylidene chloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP2127628A1
Jurisdiction
EP
Classification
—
Expires
2009-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Ranbaxy Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.